Straumann
STMN.SWPrivate Company
Total funding raised: $750M
Overview
Straumann's mission is to enable dental professionals to restore patient smiles and confidence through premium, evidence-based solutions. It has achieved global leadership in dental implantology through pioneering surface technologies like SLActive®, strategic acquisitions, and building a comprehensive digital workflow ecosystem. The company's strategy focuses on driving growth by expanding its clear aligner business, deepening its digital and regenerative medicine offerings, and leveraging its strong brand and educational infrastructure to capture market share in high-growth regions.
Technology Platform
An integrated ecosystem combining proprietary dental implant surface technologies (SLActive®), a seamless digital workflow (scan, plan, guide, restore), and a comprehensive regenerative biomaterials portfolio for bone and tissue augmentation.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Straumann holds a leadership position in the premium dental implant and digital solutions segment, competing directly with Envista (Nobel Biocare) and Dentsply Sirona. In clear aligners and scanners, Align Technology is the primary competitor. The company differentiates through its integrated ecosystem, strong brand heritage, and direct educational support for clinicians.